We work to advance and promote human-centric, nonanimal approaches in science research.
Worldwide
Joined September 2013
- Tweets4K
- Following2K
- Followers1.7K
- Likes4.5K
The @BioMed21 Collaboration will be coming together this week to strategize on identifying practical strategies to accelerate the development, validation, regulatory uptake & adoption of NAMs across Europe.
📢 Stay tuned for key insights, recos and outcomes of the workshop.
We are pleased to share our new paper, “Awareness and perspectives of translational assessment tools in preclinical research: insights from a survey”, published in the NAM Journal.
Read the full paper: sciencedirect.com/science/ar…
The US @NIH has appointed a champion of human-relevant research, Dr. Warren Casey , to lead its newly established Office of Research Innovation, Validation & Application (ORIVA).
The appointment signals continued momentum toward non-animal methods in biomedical research.
U.S. @NIH has awarded $7M to 20 research teams developing innovative technologies that aim to reduce & replace the use of animals in biomedical research.
Learn more about the awarded teams: herox.com/Complement-ARIE-RT…
An important milestone for modern biomedical research!
The @OHSUNews has approved a resolution to transform the Oregon National Primate Research Center into a leading center for non-animal research while substantially reducing the use of monkeys.
Our new report, "Funding for Non-Animal Science – A Moonshot for NAMs in Europe" highlights a clear message from a recent @Europarl_EN roundtable: EU must move beyond developing NAMs and focus on implementation, regulatory uptake & real-world impact.
📰 biomed21.org/wp-content/uplo…
Missed our webinar on rare diseases & use of New Approach Methodologies (NAMs)?
The recording is now available! ▶️ youtube.com/watch?v=02BQ9JwB…
📄 Learn more about this initiative - read our white paper: biomed21.org/wp-content/uplo…
Join our webinar on Rare Disease Research & Drug Development with NAMs in the EU.
We'll explore how human-relevant NAMs, incl. advanced 𝘪𝘯 𝘷𝘪𝘵𝘳𝘰 systems & 𝘪𝘯 𝘴𝘪𝘭𝘪𝘤𝘰 models, can help transform rare disease modelling & accelerate drug dev.
🔗events.teams.microsoft.com/e…
New funding opportunity from the US @NIH supporting centers advancing non-animal methods (NAMs) and human-based research technologies. Facilities focused primarily on animal research are not among the priorities of this announcement.
💡Learn more & apply: files.simpler.grants.gov/opp…
We were pleased to attend Ombion Centre for Animal-free Biomedical Translation’s scientific conference, where they shared news of our "Human by Design" course. Thanks Valentin Salamone & Ombion for introducing the course & congrats on a successful event! biomed21.org/2026/02/human-b…
📡 BIG NEWS! 📡 We’re excited to announce that, together with @humaneworldorg & @UniUtrecht, we're developing a course that will train the next generation of researchers in animal-free science!
Learn more & register your interest in our latest blog post: biomed21.org/2026/02/human-b…
📢 Something exciting is on the horizon for those who want to move beyond animal research.
We’re joining forces with international partners to launch a bold project to accelerate the growing shift toward more human-relevant science.
More details coming tomorrow!
On #WorldCancerDay, it’s time to rethink how we study this disease. Over 90% of cancer drugs that pass animals tests fail in human trials—a sign we need a change. The future of cancer research is human-centric, data-driven & interdisciplinary—we’re working to make that a reality.
🚀 ICYMI: The @BioMed_21 Collaboration has launched a bold new moonshot policy paper calling for a transformative shift in biomedical research—toward human-specific, non-animal methods.
Read the full paper here: biomed21.org/wp-content/uplo…
BioMed21 Collaboration retweeted
ICYMI: Our new “moonshot” policy paper with @BioMed_21 calls for a bold shift from outdated animal tests to human-relevant, animal-free methods that better predict how diseases & treatments affect people.
Read more in our latest @POLITICOEurope article: politico.eu/sponsored-conten…
Our work to progress human-centric, non-animal methods has never been more important, and we look forward to continuing our work in 2026 and beyond to make this global vision a reality. 🎉
Happy holidays to our partners, members and supporters. Thank you for your continued commitment to advancing human-centric nonanimal science. We look forward to building on our shared progress in the new year as we work together to better protect people, animals and our planet.
We are proud to announce our new moonshot policy paper, calling for a transformative "moonshot" in biomedical research: accelerating the shift to human-relevant, non-animal technologies to tackle major public health challenges. 🚀🧪🧬
🔗biomed21.org/wp-content/uplo…
📢 BREAKING: @EU_Commission’s newly introduced Biotech Act formally recognizes non-animal methods (NAMs) as “critical research & technology infrastructure”, showing that our, & @humaneworldorg's recommendations were taken into account! This is great news for animal-free science!
